Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARGX Argenx SE

盘后交易 06-25 17:15:00 EDT

888.65

+36.15

+4.24%

盘后888.65

+0.000.00%

17:02 EDT

最高895.74	最低862.82	成交量53.18万
今开862.82	昨收852.50	日振幅3.86%
总市值549.93亿	流通市值543.55亿	总股本6,188万
成交额4.72亿	换手率0.87%	流通股本6,117万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARGX","market":"US","secType":"STK","nameCN":"Argenx SE","latestPrice":888.65,"timestamp":1782417600000,"preClose":852.5,"halted":0,"volume":531817,"hourTrading":{"tag":"盘后","latestPrice":888.65,"preClose":888.65,"latestTime":"17:02 EDT","volume":64498,"amount":57316913.291260004,"timestamp":1782421336362,"change":0,"changeRate":0,"amplitude":0.000394},"delay":0,"changeRate":0.04240469208211141,"floatShares":61166252,"shares":61883400,"eps":22.49267,"marketStatus":"盘后交易","change":36.15,"latestTime":"06-25 17:15:00 EDT","open":862.82,"high":895.7416,"low":862.82,"amount":471558698.36218,"amplitude":0.038618,"askPrice":906.25,"askSize":2,"bidPrice":871.41,"bidSize":2,"shortable":3,"etf":0,"ttmEps":22.49267,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782432000000},"marketStatusCode":4,"adr":1,"adrRate":1,"listingDate":1495080000000,"exchange":"NASDAQ","adjPreClose":852.5,"preHourTrading":{"tag":"盘前","latestPrice":863.92,"preClose":852.5,"latestTime":"09:29 EDT","volume":1477,"amount":1270851.5652,"timestamp":1782394199999,"change":11.42,"changeRate":0.013396,"amplitude":0.020094},"postHourTrading":{"tag":"盘后","latestPrice":888.65,"preClose":888.65,"latestTime":"17:02 EDT","volume":64498,"amount":57316913.291260004,"timestamp":1782421336362,"change":0,"changeRate":0,"amplitude":0.000394},"volumeRatio":1.095625,"impliedVol":0.3636,"impliedVolPercentile":0.51},"requestUrl":"/m/hq/s/ARGX","defaultTab":"news","newsList":[{"id":"1123056084","title":"异动解读｜Argenx SE盘中上涨4.21%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1123056084","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123056084?lang=zh_cn&edition=full","pubTime":"2026-06-26 00:15","pubTimestamp":1782404105,"startTime":"0","endTime":"0","summary":"6月25日，Argenx SE盘中上涨4.21%，报887.71美元/股，成交额2.36亿美元。消息面上，法国巴黎银行近日首次覆盖Argenx，给予\"跑赢大盘\"评级，目标价1,219美元，较当前股价隐含约37%的上行空间，明显高于市场共识目标价1,064.53美元，对市场情绪形成持续提振。此外，公司核心产品Vyvgart已于今年5月获FDA批准扩展至全血清型重症肌无力患者，叠加一季度EPS 5.52美元超预期，基本面支撑推动股价延续涨势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159712045","title":"异动解读｜Argenx SE盘前上涨3.55%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1159712045","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159712045?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:07","pubTimestamp":1782288430,"startTime":"0","endTime":"0","summary":"6月24日，Argenx SE盘前上涨3.55%，报868.83美元/股，成交额2.03万美元。消息面上，法国巴黎银行近日将Argenx评级为\"跑赢大盘\"，并给出1,219美元的目标价，较当前股价隐含约40%的上行空间。据FactSet数据，该股分析师平均评级为\"买入\"，平均目标价为1,064.53美元。法国巴黎银行的目标价明显高于市场共识，对市场情绪形成积极提振，推动股价延续近日涨势。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注开发用于治疗严重自身免疫性疾病的差异化疗法。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178462515","title":"异动解读｜Argenx SE夜盘上涨5.46%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1178462515","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178462515?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:02","pubTimestamp":1782284520,"startTime":"0","endTime":"0","summary":"6月24日，Argenx SE夜盘上涨5.46%，报900.0美元/股，成交额5.13万美元。消息面上，法国巴黎银行近日将Argenx评级为\"跑赢大盘\"，并给出1,219美元的目标价，较当前股价隐含较大上行空间。据FactSet数据，该股分析师平均评级为\"买入\"，平均目标价为1,064.53美元。法国巴黎银行的目标价明显高于市场共识，对市场情绪形成积极提振，推动股价延续近日涨势。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注开发用于治疗严重自身免疫性疾病的差异化疗法。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195743704","title":"异动解读｜Argenx SE盘中上涨3.08%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1195743704","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195743704?lang=zh_cn&edition=full","pubTime":"2026-06-24 00:39","pubTimestamp":1782232759,"startTime":"0","endTime":"0","summary":"6月23日，Argenx SE盘中上涨3.08%，报931.58美元/股，成交额1.34亿美元。消息面上，法国巴黎银行近日将Argenx评级为\"跑赢大盘\"，并给出1,219美元的目标价，较当前股价隐含约31%的上行空间。据FactSet数据，该股分析师平均评级为\"买入\"，平均目标价为1,064.53美元。法国巴黎银行的目标价明显高于市场共识，对市场情绪形成积极提振。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注开发用于治疗严重自身免疫性疾病的差异化疗法。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197954784","title":"异动解读｜Argenx SE盘中上涨3.71%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1197954784","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197954784?lang=zh_cn&edition=full","pubTime":"2026-06-23 00:13","pubTimestamp":1782144810,"startTime":"0","endTime":"0","summary":"6月23日，Argenx SE盘中上涨3.71%，报910.27美元/股，成交额1.9亿美元。消息面上，法国巴黎银行近日将argenx评级为\"跑赢大盘\"，并给出1,219美元的目标价，较当前股价隐含约34%的上行空间。据FactSet数据，该股分析师平均评级为\"买入\"，平均目标价为1,064.53美元。法国巴黎银行的目标价明显高于市场共识，对市场情绪形成积极提振。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注开发用于治疗严重自身免疫性疾病的差异化疗法。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107841283","title":"异动解读｜Argenx SE盘中上涨6.11%，报894.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107841283","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107841283?lang=zh_cn&edition=full","pubTime":"2026-06-06 00:15","pubTimestamp":1780676152,"startTime":"0","endTime":"0","summary":"6月6日，Argenx SE盘中上涨6.11%，报894.36美元/股，成交额3.9亿美元。Argenx SE所在的生物科技行业中，个股中，BioCardia涨34.34%，安进涨2.54%，艾伯维公司涨1.92%，福泰制药涨1.46%，吉利德科学涨1.11%。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注于开发用于治疗严重自身免疫性疾病的差异化疗法，公司于2008年在荷兰成立，2014年转为上市有限责任公司。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170531813","title":"财报前瞻｜Argenx SE本季度营收预计增65.79%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1170531813","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170531813?lang=zh_cn&edition=full","pubTime":"2026-04-30 10:10","pubTimestamp":1777515039,"startTime":"0","endTime":"0","summary":"Argenx SE将于2026年05月07日盘前发布季度财报，市场聚焦Vyvgart放量与利润弹性。市场一致预期本季度Argenx SE营收为13.19亿美元，同比增长65.79%；调整后每股收益为5.38美元，同比增长134.87%；EBIT为4.08亿美元，同比增长230.92%，一致预期暂未提供毛利率与净利润或净利率的具体预测，公司上季度披露材料中未见针对本季度的明确营收指引。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Argenx SE本季度营收预计增65.79%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146795629","title":"财报前瞻｜Argenx SE本季度营收预计增82.85%，市场观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1146795629","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146795629?lang=zh_cn&edition=full","pubTime":"2026-02-19 10:15","pubTimestamp":1771467344,"startTime":"0","endTime":"0","summary":"Argenx SE将于2026年02月26日发布最新季度财报，市场关注Vyvgart适应症拓展与盈利延续为核心主线。市场一致预期本季度Argenx SE营收为12.91亿美元，同比增加82.85%；调整后每股收益为5.73美元，同比增加33.57%。公司未披露本季度毛利率与净利率的量化预测。上季度Argenx SE营收11.51亿美元，同比增长95.51%；毛利率59.61%；归属母公司净利润3.44亿美元；净利率29.90%；调整后每股收益5.18美元，同比增长272.66%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Argenx SE本季度营收预计增82.85%，市场观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606079121","title":"Argenx Se盘中异动 早盘股价大涨5.06%报875.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606079121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606079121?lang=zh_cn&edition=full","pubTime":"2026-01-27 23:40","pubTimestamp":1769528443,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日23时40分，Argenx Se股票出现异动，股价大幅上涨5.06%。截至发稿，该股报875.32美元/股，成交量16.7804万股，换手率0.27%，振幅3.47%。Argenx Se股票所在的生物技术行业中，整体涨幅为1.47%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127234043a6b3af2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127234043a6b3af2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1983260115.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","LU0320765992.SGD","BK4588","IE0009355771.USD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4585","BK4505","IE0034235188.USD","LU2324357040.USD","IE00B2B36J28.USD","BK4139","ARGX","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125206528","title":"财报前瞻｜Argenx SE本季度营收预计增0.82，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1125206528","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125206528?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:00","pubTimestamp":1767578435,"startTime":"0","endTime":"0","summary":"Argenx SE将于2026年01月12日发布最新季度财报，市场关注本季度收入与盈利的持续改善、核心产品放量与费用效率的平衡。市场一致预期显示，本季度Argenx SE总收入预计为12.83亿美元，同比增长81.79%；毛利率预计维持高位；净利率与归母净利润走势改善；调整后每股收益预计为5.77美元，同比增长3.38%。上季度Argenx SE实现营收11.51亿美元，同比增长95.51%；毛利率59.61%；归属母公司净利润3.44亿美元，净利率29.90%，环比增长40.31%；调整后每股收益5.18美元，同比增长2.73%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Argenx SE本季度营收预计增0.82，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516390377","title":"富国银行：维持argenx(ARGX.US)评级，由增持调整至增持评级, 目标价由723.00美元调整至741.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516390377","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516390377?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:31","pubTimestamp":1740763885,"startTime":"0","endTime":"0","summary":"富国银行：维持argenx(ARGX.US)评级，由增持调整至增持评级, 目标价由723.00美元调整至741.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01013148469987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514337690","title":"Citizens Capital Markets：维持argenx(ARGX.US)评级，由优于大市调整至优于大市评级, 目标价由696.00美元调整至701.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514337690","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514337690?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757319,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：维持argenx(ARGX.US)评级，由优于大市调整至优于大市评级, 目标价由696.00美元调整至701.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28234148468149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142674592","title":"argenx 2024年第四季度GAAP每股收益$11.79，同比增长至$(1.68)；销售额$7.6122亿，高于$7.0628亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1142674592","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142674592?lang=zh_cn&edition=full","pubTime":"2025-02-27 14:22","pubTimestamp":1740637328,"startTime":"0","endTime":"0","summary":"argenx公布季度每股收益为$11.79。公司季度销售额为$7.6122亿，超过分析师一致预期的$7.0628亿，超出7.78%。与去年同期$4.1784亿销售额相比，同比增长了82.18%。以上内容来自Benzinga Earnings专栏，原文如下：argenx  reported quarterly earnings of $11.79 per share. This is a 801.79 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $761.22 million which beat the analyst consensus estimate of $706.28 million by 7.78 percent.  This is a 82.18 percent increase over sales of $417.84 million the same period last ye","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"argenx 2024年第四季度GAAP每股收益$11.79，同比增长至$(1.68)；销售额$7.6122亿，高于$7.0628亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AEP","CSGP","CSWI","MDLZ","QLD","INTU","FOXA","TW","CPB","GEN","BIIB","CWST","LOGI","PSQ","USAW.SI","LU0053671581.USD","NTRA","JBHT","COO","GILD","WBA","QRVO","META","EXPE","ADI","ESLT","AVGO","NDAQ","MNQmain","MKTX","CCEP","INSM","TMUS","NICE","NTES","SNPS","CHKP","KHC","CSCO","MMYT","NWSA","RGEN","SRPT","TXN","COIN","BSY","FFIV","SBAC","LULU","ROP","RADX","NQmain","PEP","ALNY","LSTR","EWBC","PLTR","QCOM","QXO","NTNX","INCY","SQQQ","NVDA","AFRM","PTC","ODFL","TEAM","AAL","CPRT","NFLX","FAST","FTAI","WWD","OLED","CG","HTHT","MARA","APA","TLN","AAON","PCVX","RPRX","PCTY","LKQ","HOLX","SWKS","EQIX","CSX","BK4534","ADSK","DLTR","CBSH","PDD","GMAB","RYAAY","ORLY","HSIC","ROIV","CTSH","ARM","QID","DOCU","AMZN","ILMN","GTLB","ISRG","AKAM","PODD","NVIW.SI","RKLB","MNST","TTEK","LI","MKSI","EBAY","ITCI","QQQ","CHTR","FSLR","LSCC","CFLT","KDP","TPG","BK4561","MELI","BK4585","CHRW","LIN","LU0757428866.USD","FYBR","LECO","HST","HQY","NTAP","TCOM","TECH","BRKR",".IXIC","GLPI","BPOP","ERIC","ICLR","TQQQ","BK4581","PAYX","FRPT","STLD","BK4588","PNFP","CDNS","MTSI","DUOL","FSV","PAA","USJW.SI","MDB","CASY","AMGN","JKHY","NDSN","HLNE","BK4550","MANH","MEDP","NVMI","REGN","ENTG","AAPL","LAMR","INTC","ROST","TSLA","WTFC","AUR","LNW","MTCH","TSEM","DSGX","FOX","BKNG","DASH","PCAR","BMRN","SIRI","GOOGL","EA","FWONK","SAIA","AGNC","HOOD","PFG","AMAT","CINF","COKE","REG","TER","ENPH","NTRS","Z","FCNCA","EVRG","SFM","ANSS","ERIE","ARGX","LU1815336091.USD","EXE","IDXX","ONC","TTD","OTEX","ZM","ULTA","HON","JD","MIDD","CHDN","CDW","FER","HBAN","STX","MNDY","ALGN","GEHC","DOX","ROKU","CME","AMD","AZN","DPZ","GRAB","MCHP","OKTA","ADBE","LU2065731478.USD","TRMB","PARA","AXON","TSCO","SEIC","ASML","BK4593","MRVL","EXAS","DDOG","TTWO","COST","CTAS","SBUX","POOL","TSYW.SI","FTNT","CRWD","CYBR","WDC","BKR","GNTX","LNT","RGLD","CZR","LPLA","MSFT","ON","TROW","NXPI","ALAB","MPWR","MRNA","RVMD","SMCI","RIVN","DKNG","CHRD","CEG","BPMC","SOFI","WYNN","ZS","BK4086","SSNC","NBIX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2503501033","title":"HC Wainwright & Co.：重申argenx(ARGX.US)评级，由买入调整至买入评级, 目标价由670.00美元调整至717.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503501033","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503501033?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:34","pubTimestamp":1736876047,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申argenx(ARGX.US)评级，由买入调整至买入评级, 目标价由670.00美元调整至717.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/15013447459172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503570065","title":"Truist Securities：重申argenx(ARGX.US)评级，由买入调整至买入评级, 目标价由660.00美元调整至700.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503570065","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503570065?lang=zh_cn&edition=full","pubTime":"2025-01-14 23:50","pubTimestamp":1736869851,"startTime":"0","endTime":"0","summary":"Truist Securities：重申argenx(ARGX.US)评级，由买入调整至买入评级, 目标价由660.00美元调整至700.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/14235047458887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501027552","title":"Piper Sandler：维持argenx(ARGX.US)评级，由增持调整至增持评级, 目标价由620.00美元调整至725.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501027552","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501027552?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:12","pubTimestamp":1736259157,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持argenx(ARGX.US)评级，由增持调整至增持评级, 目标价由620.00美元调整至725.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07221247232536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492116716","title":"Argenx Se盘中异动 临近午盘股价大涨5.08%报638.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492116716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492116716?lang=zh_cn&edition=full","pubTime":"2024-12-17 00:42","pubTimestamp":1734367343,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日00时42分，Argenx Se股票出现异动，股价快速上涨5.08%。截至发稿，该股报638.07美元/股，成交量11.2229万股，换手率0.19%，振幅3.29%。机构评级方面，在所有33家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。Argenx Se股票所在的生物技术行业中，整体涨幅为0.68%。Argenx Se公司简介：Argenx是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217004223984c7389&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217004223984c7389&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4505","BK4585","ARGX","LU0889565916.HKD","BK4139","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171249240","title":"纳斯达克100指数年度调整在即！这11家公司或迎来股价飙升机会","url":"https://stock-news.laohu8.com/highlight/detail?id=1171249240","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171249240?lang=zh_cn&edition=full","pubTime":"2024-12-13 11:20","pubTimestamp":1734060022,"startTime":"0","endTime":"0","summary":"在今年年底的指数重组中，也可能有一些公司会被从纳斯达克100指数中移除。纳斯达克预计将在周五宣布纳斯达克100指数的变化，这对获得入选资格的公司来说不仅仅是声望问题。当宣布这一计划时，Palantir表示预期将被纳入纳斯达克100，其股价随之上涨。在纳斯达克100指数的现有成分股中，有11家公司截至11月30日的市值未进入纳斯达克综合指数的前100家非金融公司，因此可能会被移除。","market":"us","thumbnail":"https://static.tigerbbs.com/44fc2c33800eae6e4f0bbec10e83a1a5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/44fc2c33800eae6e4f0bbec10e83a1a5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"纳指100年度调整在即！这11家公司或迎来股价飙升机会","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JD","NTES","PLTR","UAL","ARGX","TCOM","MSTR","SNY","AXON","EQIX","ALNY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2485440312","title":"Argenx Se涨1.44% 股价突破600美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2485440312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485440312?lang=zh_cn&edition=full","pubTime":"2024-11-22 04:29","pubTimestamp":1732220998,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日04时29分，Argenx Se股票出现波动，股价快速拉升1.44%。截至发稿，该股报600.34美元/股，成交量24.0266万股，换手率0.40%，振幅2.70%。机构评级方面，在所有33家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。Argenx Se股票所在的生物技术行业中，整体涨幅为0.37%。Argenx Se公司简介：Argenx是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122042958a24c08eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122042958a24c08eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0320765992.SGD","BK4588","BK4139","BK4505","LU0109394709.USD","ARGX","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.argenx.com","stockEarnings":[{"period":"1week","weight":-0.0446},{"period":"1month","weight":0.0571},{"period":"3month","weight":0.2305},{"period":"6month","weight":0.009},{"period":"1year","weight":0.5007},{"period":"ytd","weight":0.0137}],"compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.0166},{"period":"3month","weight":0.1366},{"period":"6month","weight":0.0622},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0753}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Argenx Se根据荷兰法律于2008年4月25日成立，是一家私人有限责任公司（besloten vennootschap met beperkte aansprakelijkheid）。 于2014年5月28日，根据公证转换契约及修订，该公司转为上市有限责任公司（naamloze vennootschap）。 该公司是一家处于商业阶段的、全球性的、完全整合的生物制药公司，开发用于治疗严重自身免疫性疾病的差异化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.007923},{"month":2,"riseRate":0.333333,"avgChangeRate":0.026997},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.02217},{"month":4,"riseRate":0.777778,"avgChangeRate":0.0372},{"month":5,"riseRate":0.555556,"avgChangeRate":0.061118},{"month":6,"riseRate":0.8,"avgChangeRate":0.050427},{"month":7,"riseRate":0.666667,"avgChangeRate":0.0867},{"month":8,"riseRate":0.666667,"avgChangeRate":0.01751},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.022149},{"month":10,"riseRate":0.666667,"avgChangeRate":0.037064},{"month":11,"riseRate":0.777778,"avgChangeRate":0.116374},{"month":12,"riseRate":0.444444,"avgChangeRate":0.116024}],"exchange":"NASDAQ","name":"Argenx SE","nameEN":"Argenx SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Argenx SE,ARGX,Argenx SE股票,Argenx SE股票老虎,Argenx SE股票老虎国际,Argenx SE行情,Argenx SE股票行情,Argenx SE股价,Argenx SE股市,Argenx SE股票价格,Argenx SE股票交易,Argenx SE股票购买,Argenx SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}